Ian Macdonald
Nurse Practitioner · Tallahassee, FLNPI 1780063982
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $3,060 of the $4,830 with a category attached, or 63.4%. Si-bone, Inc. accounts for 97.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2021 at $4,619 and has fallen 98.6% since, to $63 in 2025. Among nurse practitioner clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 27 payments — averaging $178.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Si-bone, Inc.$5K
- Bioventus LLC$24
- CGG Medical Inc$23
- Globus Medical$20
- Orthofix Medical, Inc.$19
- Pacira Pharmaceuticals Incorporated$13
What the payments were for
- Consulting fees$3,06063%
- Travel & lodging$1,31227%
- Food & beverage$4579%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Si-bone, Inc. | 22 | $4,731 |
| Bioventus LLC | 1 | $24 |
| CGG Medical Inc | 1 | $23 |
| Globus Medical | 1 | $20 |
| Orthofix Medical, Inc. | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iFuse Implant$3,966
How this compares
$4,830 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 145 | $1,590 |
| Tizanidine Hcl | 139 | $1,267 |
| Celecoxib | 64 | $1,131 |
| Nabumetone | 23 | $533 |
| Oxycodone Hcl | 29 | $376 |
| Cyclobenzaprine Hcl | 27 | $374 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $191 |
| Pregabalin | 12 | $171 |
| Methylprednisolone | 13 | $105 |
| Tramadol Hcl | 17 | $71 |
| Meloxicam | 13 | $40 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Tallahassee
- Jolanta BaginskiClearwater$494K
- Adissa PerezWinter Park$370K
- April WessonTampa$342K
- Margarita FernandezMiami$311K
- Stephanie SimmermanNaples$283K
- Claudette WalkerPonte Vedra Beach$271K
- Lisa NodzonTampa$246K
- Ashima BahlTampa$226K
- Maya BloombergMiami$202K
- Jennifer PuleoTampa$171K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.